Sheppard Pratt Psychiatry

Topics

• Parkinson's Disease Mechanisms and Treatments 308
• Schizophrenia research and treatment 117
• Dementia and Cognitive Impairment Research 71
• Opioid Use Disorder Treatment 66
• Stress Responses and Cortisol 62
• Tryptophan and brain disorders 54
• Bipolar Disorder and Treatment 32
• Functional Brain Connectivity Studies 32
• Substance Abuse Treatment and Outcomes 31
• Treatment of Major Depression 29
• Suicide and Self-Harm Studies 28
• Telomeres, Telomerase, and Senescence 28

Most cited

1. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.

   The Lancet. Neurology · 2024 · 536 citations · Daniel Weintraub

2. Parkinson disease-associated cognitive impairment.

   Nature reviews. Disease primers · 2021 · 1,137 citations · Daniel Weintraub

3. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.

   The Lancet. Neurology · 2023 · 586 citations · Daniel Weintraub

4. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.

   Movement disorders : official journal of the Movement Disorder Society · 2023 · 324 citations · Daniel Weintraub

5. Frontostriatal salience network expansion in individuals in depression.

   Nature · 2024 · 251 citations · Eric Goldwaser

6. The neuropsychiatry of Parkinson's disease: advances and challenges.

   The Lancet. Neurology · 2022 · 349 citations · Daniel Weintraub